Logo image of CANO

CANO HEALTH INC (CANO) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CANO - US13781Y2028 - Common Stock

2.3 USD
-0.05 (-2.13%)
Last: 2/2/2024, 8:04:00 PM
1.17 USD
-1.13 (-49.13%)
Pre-Market: 2/5/2024, 8:39:57 AM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CANO. CANO was compared to 103 industry peers in the Health Care Providers & Services industry. CANO has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, CANO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • CANO had negative earnings in the past year.
  • In the past year CANO has reported a negative cash flow from operations.
CANO Yearly Net Income VS EBIT VS OCF VS FCFCANO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -50M -100M -150M -200M

1.2 Ratios

  • CANO has a Return On Assets of -47.69%. This is amonst the worse of the industry: CANO underperforms 85.22% of its industry peers.
Industry RankSector Rank
ROA -47.69%
ROE N/A
ROIC N/A
ROA(3y)-7.72%
ROA(5y)N/A
ROE(3y)-77.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CANO Yearly ROA, ROE, ROICCANO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -50 -100

1.3 Margins

  • CANO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CANO Yearly Profit, Operating, Gross MarginsCANO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 -2 -4 -6 -8

0

2. Health

2.1 Basic Checks

  • CANO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CANO has been reduced compared to 1 year ago.
  • Compared to 1 year ago, CANO has a worse debt to assets ratio.
CANO Yearly Shares OutstandingCANO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 100M 200M 300M
CANO Yearly Total Debt VS Total AssetsCANO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 0.33, we must say that CANO is in the distress zone and has some risk of bankruptcy.
  • CANO has a worse Altman-Z score (0.33) than 66.09% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.33
ROIC/WACCN/A
WACC5.13%
CANO Yearly LT Debt VS Equity VS FCFCANO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • CANO has a Current Ratio of 0.40. This is a bad value and indicates that CANO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CANO has a worse Current ratio (0.40) than 91.30% of its industry peers.
  • CANO has a Quick Ratio of 0.40. This is a bad value and indicates that CANO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CANO's Quick ratio of 0.40 is on the low side compared to the rest of the industry. CANO is outperformed by 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
CANO Yearly Current Assets VS Current LiabilitesCANO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 100M 200M 300M

4

3. Growth

3.1 Past

  • CANO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -343.95%.
  • CANO shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.69%.
  • Measured over the past years, CANO shows a very strong growth in Revenue. The Revenue has been growing by 96.42% on average per year.
EPS 1Y (TTM)-343.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-299.43%
Revenue 1Y (TTM)25.69%
Revenue growth 3Y96.42%
Revenue growth 5YN/A
Sales Q2Q%18.51%

3.2 Future

  • CANO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -50.04% yearly.
  • Based on estimates for the next years, CANO will show a small growth in Revenue. The Revenue will grow by 2.24% on average per year.
EPS Next Y-1383.78%
EPS Next 2Y-122.5%
EPS Next 3Y-50.04%
EPS Next 5YN/A
Revenue Next Year16.84%
Revenue Next 2Y1.95%
Revenue Next 3Y2.61%
Revenue Next 5Y2.24%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CANO Yearly Revenue VS EstimatesCANO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
CANO Yearly EPS VS EstimatesCANO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 -50 -100 -150

0

4. Valuation

4.1 Price/Earnings Ratio

  • CANO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CANO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CANO Price Earnings VS Forward Price EarningsCANO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CANO Per share dataCANO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400

4.3 Compensation for Growth

  • CANO's earnings are expected to decrease with -50.04% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-122.5%
EPS Next 3Y-50.04%

0

5. Dividend

5.1 Amount

  • No dividends for CANO!.
Industry RankSector Rank
Dividend Yield N/A

CANO HEALTH INC / CANO FAQ

Can you provide the ChartMill fundamental rating for CANO HEALTH INC?

ChartMill assigns a fundamental rating of 1 / 10 to CANO.


Can you provide the valuation status for CANO HEALTH INC?

ChartMill assigns a valuation rating of 0 / 10 to CANO HEALTH INC (CANO). This can be considered as Overvalued.


What is the profitability of CANO stock?

CANO HEALTH INC (CANO) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for CANO stock?

The Earnings per Share (EPS) of CANO HEALTH INC (CANO) is expected to decline by -1383.78% in the next year.